Teal Ventures

Cooler Heads develops a portable scalp cooling system for chemotherapy patients. Its product Amma™ offers people with cancer the choice of maintaining their hair during chemotherapy, empowering them to control how they experience treatment side effects.

Nudj Health is a mental health care center focused on integrating lifestyle wellness into patient care. The company provides comprehensive healthcare services aimed at improving outcomes for patients with chronic diseases. By delivering integrated, whole-person, and continuous care, Nudj Health extends its services beyond traditional clinical settings. It employs a collaborative care model that utilizes evidence-based, Medicare-approved pathways, addressing interconnected lifestyle factors that contribute to health. This approach enables healthcare providers to enhance patient satisfaction while reducing the need for acute care and outpatient services.

Nudj Health is currently operating in stealth mode.

Diagenta is a healthcare company that provides telehealth and patient monitoring services through a comprehensive platform designed for on-demand healthcare delivery. The platform facilitates rapid triage services, allowing for efficient assessment of patient needs and appropriate care direction. Diagenta's offerings include hospital-grade capabilities that patients can access from home, which helps alleviate the burden on overcrowded facilities and reduces waiting times. The company's medical platform connects patients with healthcare practitioners, enabling house calls and utilizing an electronic health record system along with diagnostic and treatment tools. This approach delivers the functionality of an urgent care clinic directly to patients, offering a compact, wirelessly connected solution staffed by licensed healthcare professionals and supervised in real-time.

NoniGenex is a company focused on developing disease testing kits that measure neutralizing antibodies. Its primary product is a test that assesses protection against COVID-19, allowing users to detect levels of immunity and respond effectively to the virus. By providing reliable measurements of neutralizing antibodies, NoniGenex aims to enhance the understanding of individual immune responses and support public health efforts in combating infectious diseases.

Cooler Heads develops a portable scalp cooling system for chemotherapy patients. Its product Amma™ offers people with cancer the choice of maintaining their hair during chemotherapy, empowering them to control how they experience treatment side effects.

Physician Retraining and Reentry (PRR) is an organization that provides an online educational program aimed at re-training and re-educating long-tenured physicians. In collaboration with the University of California San Diego School of Medicine faculty, PRR offers a comprehensive platform that includes online modules covering essential topics such as cardiology, dermatology, and medical record management. This initiative is designed to facilitate the transition of experienced doctors back into practice, particularly in primary care, addressing the growing physician shortage in the nation. By equipping physicians with the necessary knowledge and skills, PRR plays a vital role in enhancing the healthcare workforce and improving patient access to medical care.

19Labs Inc., established in 2015, specializes in developing innovative telehealth solutions. Headquartered in Redwood City, California, with a satellite office in Brentwood Bay, Canada, the company offers GALE Telehealth 2.0, a point-of-care system comprising deployment platforms and management systems. Their product suite includes GALE FLORENCE (a compact solution for first aid supplies), GALE MINI (a portable diagnostic device kit), and GALE MAX (an office tabletop kiosk). These solutions enable patients to connect with healthcare providers via video calls, summon on-call practitioners instantly, and share real-time diagnostic readings. Serving consumers, medical care providers, and employers, 19Labs aims to bring clinic-level care to users' locations.

Trials.ai is a technology company based in San Diego, California, specializing in the optimization of clinical trials through its innovative platform. Founded in 2015, the company offers a comprehensive system that integrates various functionalities, including electronic data capture, clinical trial management, patient-reported outcomes, and analytics, all designed to streamline trial management. By leveraging artificial intelligence, Trials.ai assists pharmaceutical, biotech, and medical device companies in designing efficient clinical trials, ultimately reducing the time and costs associated with bringing new treatments to market. The platform addresses challenges such as patient eligibility, visit management, and protocol adherence, guiding both researchers and patients through the trial process. Additionally, Trials.ai taps into vast amounts of previously underutilized data, providing unique insights and recommendations to trial sponsors for optimizing their trial protocols. This approach aims to enhance the success rate of clinical trials and ensure that effective treatments reach patients more quickly.

NeuraLace Medical, Inc. is a San Diego-based technology company founded in 2016 that specializes in developing a hardware-based neuromodulation platform aimed at managing neuropathic pain. The company focuses on creating a non-invasive interface to deliver sustainable relief from chronic pain, specifically targeting sensory nerve fibers with short bursts of magnetic pulses. This innovative approach offers a non-drug pain management solution that can be implemented in pain clinics, allowing patients to receive treatments while minimizing the risks associated with opioid addiction and surgical interventions. NeuraLace Medical is dedicated to bridging the gap between technology and neurology to enhance the quality of life for individuals suffering from chronic nerve pain.

FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.